Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Icahn School of Medicine at Mount Sinai
New York, New York
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 124
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Eric Schadt | Conflict of Interest | Sema4 | $550,000 - $599,999 | 2019 |
| Joshua Bederson | Conflict of Interest | Surgical Theater | $300,000 - $349,999 | 2016 |
| Hugh Sampson | Conflict of Interest | DBV Technologies | $250,000 - $299,999 | 2016 |
| Johan Bjorkegren | Conflict of Interest | Clinical Gene Networks | $200,000 - $249,999 | 2016 |
| Edward Schuchman | Conflict of Interest | Plexcera Therapeutics | $200,000 - $249,999 | 2014 |
| Premkumar Reddy | Conflict of Interest | Onconova Therapeutics | $150,000 - $199,999 | 2018 |
| M.v. Ramana Reddy | Conflict of Interest | Onconova Therapeutics, Inc. | $150,000 - $199,999 | 2013 |
| Eric Schadt | Conflict of Interest | Sema4 | $150,000 - $199,999 | 2019 |
| Johan Bjorkegren | Conflict of Interest | Clinical Gene Networks | $80,000 - $99,999 | 2016 |
| Indu Ayappa | Conflict of Interest | New York University (NYU) | $80,000 - $99,999 | 2016 |
| David Yankelvitz | Conflict of Interest | Cornell Research Foundation | $60,000 - $79,999 | 2017 |
| David Rapoport | Conflict of Interest | New York University (NYU) | $60,000 - $79,999 | 2017 |
| David Rapoport | Conflict of Interest | Fisher and Paykel Healthcare | $60,000 - $79,999 | 2017 |
| Paul Kenny | Conflict of Interest | Eolas Therapeutics | $40,000 - $59,999 | 2016 |
| Ronald Danis | Conflict of Interest | EyeKor LLC | $40,000 - $59,999 | 2016 |
| Indu Ayappa | Conflict of Interest | New York Universiy | $40,000 - $59,999 | 2017 |
| Douglas Dieterich | Conflict of Interest | Gilead Sciences, Inc. | $40,000 - $59,999 | 2014 |
| Noam Harpaz | Conflict of Interest | Abbvie | $40,000 - $59,999 | 2016 |
| Edward Schuchman | Conflict of Interest | Genzyme Corporation | $20,000 - $39,999 | 2014 |
| Jean Frederic Colombel | Conflict of Interest | AbbVie | $20,000 - $39,999 | 2019 |
| Johan M. Bjorkegren | Conflict of Interest | Clinical Gene Networks | $20,000 - $39,999 | 2016 |
| Edward Schuchman | Conflict of Interest | Plexcera Therapeutics | $20,000 - $39,999 | 2014 |
| Douglas Dieterich | Conflict of Interest | Merck & Co., Inc. | $20,000 - $39,999 | 2014 |
| Marc Gillinov | Conflict of Interest | Edwards Life Sciences | $20,000 - $39,999 | 2017 |
| Jeremiah Faith | Conflict of Interest | Vedanta Biosciences | $20,000 - $39,999 | 2019 |
| Jeremiah Faith | Conflict of Interest | Vedanta Biosciences | $20,000 - $39,999 | 2019 |
| Johan Bjorkegren | Conflict of Interest | Clinical Gene Networks | $20,000 - $39,999 | 2016 |
| Jeffrey Newcorn | Conflict of Interest | NLS | $20,000 - $39,999 | 2018 |
| Marla Dubinsky | Conflict of Interest | AbbVie | $20,000 - $39,999 | 2019 |
| Alison Goate | Conflict of Interest | Denali Therapeutics | $10,000 - $19,999 | 2019 |
| Bruce Sands | Conflict of Interest | AbbVie | $10,000 - $19,999 | 2019 |
| Allison Goate | Conflict of Interest | Denali Therapeutics | $10,000 - $19,999 | 2019 |
| Premkumar Reddy | Conflict of Interest | Onconova Therapeutics | $10,000 - $19,999 | 2018 |
| Jeffrey Newcorn | Conflict of Interest | Ironshore | $10,000 - $19,999 | 2018 |
| Noam Harpaz | Conflict of Interest | Celgene | $10,000 - $19,999 | 2016 |
| Jean-Frederic Colombel | Conflict of Interest | AbbVie | $10,000 - $19,999 | 2019 |
| Robert Desnick | Conflict of Interest | Recordati Rare Diseases | $10,000 - $19,999 | 2017 |
| Ronald Danis | Conflict of Interest | Da'An Healthcare/Sun Yat Sen University | $10,000 - $19,999 | 2016 |
| Hans Lilja | Conflict of Interest | OPKO Health | $10,000 - $19,999 | 2015 |
| Mark Lebwohl | Conflict of Interest | Pfizer Inc. | $10,000 - $19,999 | 2013 |
| Helen Mayberg | Conflict of Interest | Functional Neuroscience | $10,000 - $19,999 | 2019 |
| Jean-Frederic Colombel | Conflict of Interest | Takeda | $10,000 - $19,999 | 2019 |
| Roger Hajjar | Conflict of Interest | SUMOCOR | $10,000 - $19,999 | 2019 |
| Bruce Sands | Conflict of Interest | AbbVie, Inc. | $5,000 - $9,999 | 2017 |
| Bruce Sands | Conflict of Interest | Shire | $5,000 - $9,999 | 2017 |
| Tom Michoel | Conflict of Interest | Clinical Gene Networks | $5,000 - $9,999 | 2016 |
| Emma Guttman | Conflict of Interest | Pfizer | $5,000 - $9,999 | 2016 |
| Joel Dudley | Conflict of Interest | Personalis | $5,000 - $9,999 | 2016 |
| Dmitriy Berenzon | Conflict of Interest | Incyte Pharmaceuticals | $5,000 - $9,999 | 2014 |
| Jeffrey Newcorn | Conflict of Interest | Shire | $5,000 - $9,999 | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.